Renovos Biologics Limited

Renovos is a new regenerative medicine company capitalising on the decades of world-class stem cell and orthopaedic research from the University of Southampton. Renovos is developing next-generation regenerative medicine solutions, based on a synthetic nanoclay gel technology platform, Renovite. Renovos offers a complementary range of products and services to address the needs of researchers and clinicians, developing solutions for tissue healing that is quicker, safer and more cost-effective

Regenerative medicine,biomaterials,drug delivery,medical devices,pharmaceuticals,stem cells,cell based assays,and orthopaedics

Renovos biologics limited operates in the Biotechnology research industry.

Renovos biologics limited's revenue is 1m - 10m

Renovos biologics limited has 11 - 50 employees.